SCHEMBL9118514

SCHEMBL9118514

O=C(c1ccc(F)cc1)C1CCN(CCCCc2coc3ccc(Cl)cc3c2=O)CC1

nearest known ligand 0.59

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.53
KDM4E B2RXH2 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
ALDH1A1 P00352 1/20 0.52
HTR2C P28335 3/20 0.48
HTR7 P34969 3/20 0.48
HTR6 P50406 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9289676 0.97 KDM4E (0.53) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL9115603 0.93 HTR2A (0.57) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL9115113 0.90 HTR2A (0.53) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL9117274 0.88 ALDH1A1 (0.54) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL9117523 0.88 HTR2A (0.50) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL9115981 0.86 HTR2A (0.50) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL9115963 0.86 HTR2A (0.50) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL9115835 0.86 HTR2A (0.50) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL9116097 0.86 ALDH1A1 (0.51) HTR2AKDM4EALDH1A1HTR2C
SCHEMBL9116862 0.86 HTR2C (0.57) HTR2AKDM4ECYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995025731-A1 NOVEL 3-(φ-(4-BENZOYLPIPERIDINO)ALKYL)-4H-BENZOPYRAN-4-ONES, PREPARATION AND THERAPEUTICAL USE THEREOF PIERRE FABRE MEDICAMENT (FR) 1995-09-28 WO claimed
WO-1995025731-A1 NOVEL 3-(φ-(4-BENZOYLPIPERIDINO)ALKYL)-4H-BENZOPYRAN-4-ONES, PREPARATION AND THERAPEUTICAL USE THEREOF PIERRE FABRE MEDICAMENT (FR) 1995-09-28 WO disclosed